Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.18 USD
Change Today -0.10 / -3.05%
Volume 442.3K
CRIS On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas A. Melton Ph.D.

Former Director, Curis, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 4 different organizations across 8 different industries.

See Board Relationships
61--

Background*

Dr. Douglas A. Melton, also known as Doug, Ph.D., is an Advisor at The Experiment Fund. Dr. Melton serves as Co-Chairman of the Department of Stem Cell and Regenerative Biology at Harvard University. He has been a Co-Founder of Gilead Sciences and Ontogeny (now Curis). Dr. Melton served as the Chairman of Scientific Advisory Board at Curis Inc. from August 2000 to August 2006. Dr. Melton served as a Director of Curis Inc. since February 2000 and also served as its Member ...

Read Full Background

Corporate Headquarters*

4 Maguire Road
Lexington, Massachusetts 02421

United States

Phone: 617-503-6500
Fax: 617-503-6501

Board Members Memberships*

2000-N/A
Former Director
2000-N/A
Former Director

Education*

PhD
University of Cambridge
BA
University of Cambridge
BS
University of Illinois-Urbana-Champaign

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRIS:US $3.18 USD -0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$568.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CURIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.